Somewhat Favorable News Coverage Somewhat Unlikely to Affect Joint (NASDAQ:JYNT) Share Price

News stories about Joint (NASDAQ:JYNT) have been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Joint earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 44.6924917970625 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Several research firms have weighed in on JYNT. Zacks Investment Research cut Joint from a “buy” rating to a “hold” rating in a research report on Wednesday. ValuEngine raised Joint from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $5.86.

Shares of Joint (JYNT) traded down $0.10 on Thursday, hitting $4.70. The company’s stock had a trading volume of 28,700 shares, compared to its average volume of 19,643. The company has a market capitalization of $67.19, a price-to-earnings ratio of -6.91 and a beta of 1.53. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.32 and a current ratio of 1.32. Joint has a 52-week low of $2.66 and a 52-week high of $6.00.

Joint (NASDAQ:JYNT) last issued its earnings results on Thursday, November 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.06) by $0.03. Joint had a negative return on equity of 34.94% and a negative net margin of 6.17%. The firm had revenue of $6.55 million for the quarter, compared to analyst estimates of $6.28 million. equities analysts forecast that Joint will post -0.27 EPS for the current year.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at

About Joint

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Insider Buying and Selling by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with's FREE daily email newsletter.

Leave a Reply